Market News & Trends
A Changing Market Demands New Approaches to Drug Development
THE POINT OF DEPARTURE Due to a variety of factors, including shrinking product pipelines of many pharma companies, increasing costs associated with drug development, a…
Concert Pharmaceuticals Achieves $2-Million Milestone
Concert Pharmaceuticals, Inc. recently announced that it has achieved a $2- million milestone under its development and license agreement with Avanir Pharmaceuticals, Inc. for the…
EMD Millipore Announces Strategic Alliance on Biopharmaceutical Manufacturing
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced that EMD Millipore and Samsung BioLogics have signed an MOU (Memorandum…
Catalent & Minomic to Collaborate on New Cancer Treatment
Catalent recently announced that it is collaborating with privately held Australian biomarker research company, Minomic International Limited, to develop MIL-38, an antibody drug conjugate (ADC)…
US-Manufactured API Urea From FDA-Registered Facility Available Q4 2014
Bangor, PA – BioSpectra announces its cGMP, US-manufactured ICH Q7-based Urea, intended for use as an active pharmaceutical ingredient (API), will be produced in its…
TxCell Granted Five New Patents in Major Global Territories
TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, recently announced that five new…
MRC Technology Negotiates License With Bio-Techne
MRC Technology recently announced it has negotiated a license for a protein synthesis technology, Genetically encoded Orthogonal Protection and Activated Ligation (GOPAL), with Bio-Techne, (Techne…
3M Hosted Innovation Symposium on Drug Delivery
Approximately 100 industry leaders, advocates, regulators, and academic community members stepped away from their projects on Thursday, June 12, to take part in the Catalent…
Capsugel & Cardax to Collaborate on Development of Proprietary Products
Capsugel & Cardax to Collaborate on Development of Proprietary Products Capsugel and Cardax, Inc. recently announced a collaboration to develop unique astaxanthin products for the…
Boehringer Ingelheim Announces US Filing for Fixed-Dose Combination Drug
Boehringer Ingelheim recently announced that the US FDA accepted for review the NDA for the fixed-dose combination (FDC) of tiotropium and olodaterol delivered via the…
Global Market for DNA Vaccines to Reach $2.7 Billion
The vaccine industry is rapidly changing from a mostly empirical approach to a rational design approach. Rapid developments in molecular biology, DNA synthesis, and immunobiology…
3M Celebrates 25th Anniversary of Breath-Actuated Inaher
It’s been happening about once every 6.6 seconds for the past 25 years, and you probably didn’t even realize it. Is it a baby being…
3M DDS Announces Collaboration With Presspart Group
ST. PAUL, Minn. – August 13, 2014 – 3M Drug Delivery Systems Division recently announced a new collaborative agreement with Presspart Group (a division of…
ADHD Treatment Market Value to Reach $9.9 Billion
The Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market value will rise from $6.9 billion in 2013 to $9.9 billion by 2020, with broadening diagnostic criteria a…
Global Market for DNA Vaccines to Reach $2.7 Billion
The vaccine industry is rapidly changing from a mostly empirical approach to a rational design approach. Rapid developments in molecular biology, DNA synthesis, and immunobiology…
Baxter Biologics Facility In Asia, Announces Expansion Plans
Baxter International Inc. recently announced the formal opening of its first advanced recombinant biologic facility in Singapore, and expansion plans for a new recombinant protein…
Biotech Forward Pharma Files for $200-Million IPO
Forward Pharma A/S, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis, recently announced it has filed…
Coherus’ Biosimilar Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
Coherus BioSciences, Inc. recently announced that CHS-1420, its proposed biosimilar of adalimumab (Humira), met the primary endpoint in a pivotal clinical pharmacokinetic (PK) similarity study…
Seventh Sense Biosystems Closes $16-Million Financing
Seventh Sense Biosystems, Inc. (7SBio), the pioneering developer of virtually painless blood collection and diagnostic platforms, recently announced a $16-million Series B financing from a…
Allergan Acquires LiRIS Program From TARIS Biomedical
Allergan Inc. and TARIS Holdings LLC recently announced that Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical’s lead program, LiRIS, which…
